Literature DB >> 27106607

Insights into composition/structure/function relationships of Doxil® gained from "high-sensitivity" differential scanning calorimetry.

Xiaohui Wei1, Rivka Cohen2, Yechezkel Barenholz3.   

Abstract

Thermotropic behavior of Doxil® and its generic, Lipodox®, was characterized using "high-sensitivity" differential scanning calorimetry (DSC). This is the first report that two distinct endotherms were observed in Doxil and Lipodox upon heating. The first (Tm at 51±2°C) is broad and of low enthalpy, representing the membrane lipid phase transition, which occurs despite having high (38mole%) cholesterol. The second (Tm at ∼70°C) is narrow, representing melting of the intraliposomal doxorubicin-sulfate nanocrystals. The thermograms of Doxil and Lipodox are practically identical. The membrane phase transition is similar to that of drug-free nanoliposomes of the same size and lipid composition as Doxil, suggesting lack of significant drug-membrane interaction. The melting endotherm of the intraliposomal nanocrystals is 2.0-2.5-fold narrower than that of the crystals formed in a solution of 250mM ammonium sulfate and >60mg/ml doxorubicin. This suggests that nanovolume of liposomes improves doxorubicin-sulfate crystallinity. Moreover, both phase transitions are reversible in cycled DSC scanning (15-90-15°C). This indicates an unexpected "non-leaky" phospholipid phase transition and excellent physical and chemical stabilities of Doxil after short exposure to high temperature. Reducing mole% of cholesterol results in a "leaky" membrane phase transition of higher enthalpy. Namely, high mole% cholesterol is essential for the resistance to drug leakage during phase transition. Pegylated liposomal doxorubicin in which HSPC was replaced by DPPC shows the same non-leaky phase transition but at a lower temperature, indicating this type of phase transition is not unique to Doxil. The presence of DSPE-PEG2k increases the cooperativity of the phase transition. High-sensitivity DSC helps illuminate composition/structure/function relationships of Doxil, and is useful for the equivalence/similarity studies.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  DSC; Doxorubicin; Liposomes; PLD; Thermodynamics

Mesh:

Substances:

Year:  2016        PMID: 27106607     DOI: 10.1016/j.ejpb.2016.04.011

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  16 in total

1.  Early Development Challenges for Drug Products Containing Nanomaterials.

Authors:  Jennifer H Grossman; Rachael M Crist; Jeffrey D Clogston
Journal:  AAPS J       Date:  2016-09-09       Impact factor: 4.009

2.  Triphenyl Phosphine-Functionalized Chitosan Nanoparticles Enhanced Antitumor Efficiency Through Targeted Delivery of Doxorubicin to Mitochondria.

Authors:  Jiahui Hou; Xiwei Yu; Yaping Shen; Yijie Shi; Chang Su; Liang Zhao
Journal:  Nanoscale Res Lett       Date:  2017-02-28       Impact factor: 4.703

3.  Near-Infrared Activated Release of Doxorubicin from Plasmon Resonant Liposomes.

Authors:  Shellie S Knights-Mitchell; Marek Romanowski
Journal:  Nanotheranostics       Date:  2018-06-21

4.  Cardinal Role of Intraliposome Doxorubicin-Sulfate Nanorod Crystal in Doxil Properties and Performance.

Authors:  Xiaohui Wei; Dima Shamrakov; Sioma Nudelman; Sivan Peretz-Damari; Einat Nativ-Roth; Oren Regev; Yechezkel Barenholz
Journal:  ACS Omega       Date:  2018-03-02

5.  The use of tail-anchored protein chimeras to enhance liposomal cargo delivery.

Authors:  Abbi Abdelrehim; Lior Shaltiel; Ling Zhang; Yechezkel Barenholz; Stephen High; Lynda K Harris
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

6.  A Novel, Nontoxic and Scalable Process to Produce Lipidic Vehicles.

Authors:  Nikolaos Naziris; Natassa Pippa; Costas Demetzos
Journal:  Materials (Basel)       Date:  2020-11-08       Impact factor: 3.623

7.  Quantitative Cryo-TEM Reveals New Structural Details of Doxil-Like PEGylated Liposomal Doxorubicin Formulation.

Authors:  Rickard Nordström; Lin Zhu; Johan Härmark; Yael Levi-Kalisman; Erez Koren; Yechezkel Barenholz; Genia Levinton; Dima Shamrakov
Journal:  Pharmaceutics       Date:  2021-01-19       Impact factor: 6.321

8.  Liposomal Bupivacaine (Bupigel) Demonstrates Minimal Local Nerve Toxicity in a Rabbit Functional Model.

Authors:  Yaelle Bavli; Malcolm Rabie; Yakov Fellig; Yoram Nevo; Yechezkel Barenholz
Journal:  Pharmaceutics       Date:  2021-02-01       Impact factor: 6.321

9.  Chimeric Stimuli-Responsive Liposomes as Nanocarriers for the Delivery of the Anti-Glioma Agent TRAM-34.

Authors:  Nikolaos Naziris; Natassa Pippa; Evangelia Sereti; Varvara Chrysostomou; Marta Kędzierska; Jakub Kajdanek; Maksim Ionov; Katarzyna Miłowska; Łucja Balcerzak; Stefano Garofalo; Cristina Limatola; Stergios Pispas; Konstantinos Dimas; Maria Bryszewska; Costas Demetzos
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

10.  Involvement of complement activation in the pulmonary vasoactivity of polystyrene nanoparticles in pigs: unique surface properties underlying alternative pathway activation and instant opsonization.

Authors:  Tamás Mészáros; Gergely Tibor Kozma; Taro Shimizu; Koga Miyahara; Keren Turjeman; Tatsuhiro Ishida; Yechezkel Barenholz; Rudolf Urbanics; János Szebeni
Journal:  Int J Nanomedicine       Date:  2018-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.